|
 |
sumatriptan succinateThis page contains recent news articles, when available, and an overview of sumatriptan succinate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: sumatriptan succinate (when available) Sumatriptan, an antimigraine drug, is structurally similar to serotonin. It is thought that the cerebral blood vessel constriction induced by activation of 5-HT1 receptors on those vessels may contribute to the antimigrainous effect of sumatriptan in humans. For the treatment of migraine attacks with or without aura in adults Mechanism Of Action: Sumatriptan stimulates 5-HT receptors of the 1D subtype, most likely presynaptic receptors, resulting in selective vasoconstriction of inflamed and dilated cranial blood vessels in the carotid circulation. Sumatriptan also blocks the release of vasoactive neuropeptides from perivascular trigeminal axons in the dura mater during migraine and may inhibit the release of inflammatory mediators from the trigeminal nerve. News Articles on Sumatriptan Dr Reddy's Launches Over-The-Counter Omeprazole In US - Dec 15, 2009 US sales in the July-September quarter were helped by exclusive sales of sumatriptan succinate, a generic version of GlaxoSmithKline PLC's anti-migraine ... Wall Street Journal Outsourcing steroid for Indian pharma firms - Dec 20, 2009 ...revenues from the launch of an authorised generic version of GlaxoSmithKline's migraine drug, Imitrex (sumatriptan succinate), in the US market. ... Rediff Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009 - Nov 6, 2009 Sumatriptan: Net sales of sumatriptan succinate were $16.7 million in the third quarter, a decrease of 24% from the prior quarter due to the release of ... CNNMoney.com (press release) Ranbaxy Lab flares up on turnaround Q3 numbers - Oct 25, 2009 Ranbaxy Laboratories had on 11 August 2009 received approval from US FDA for Sumatriptan Succinate tablets. Ranbaxy Laboratories manufactures and markets, ... India Infoline.com Generic Imitrex: Ranbaxy's loss is Dr Reddy's gain - Nov 25, 2008 However, it was not clear if sumatriptan succinate was one of them. ... Dr Reddy's had settled with GSK on sumatriptan succinate in October 2006 providing ... सिफी - सिफी Dr Reddy's settles patent litigation with Glaxo - Oct 11, 2006 Dr Reddy's Laboratories Ltd has settled the long-pending patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic ... Hindu Business Line Aurobindo Pharma gets FDA tentative nod for generic version of GSK … - Feb 1, 2008 Annual sales of Sumatriptan Succinate Tablets in the US to end-March 2007, were 950 mln usd, according to IMS Health (nyse: RX - news - people ) data. ... Forbes Teva Announces Tentative Approval of Sumatriptan Succinate Tablets. - Nov 29, 2006 JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for ... Free with registration - Business Wire - AccessMyLibrary.com RANBAXY GETS USFDA APPROVAL FOR SUMATRIPTAN SUCCINATE … - Aug 4, 2005 NEW DELHI, Aug 4 Asia Pulse - Ranbaxy Laboratories (BSE:600359) said it has received USFDA tentative approval for Sumatriptan Succinate Tablets. ... $4.95 - AsiaPulse News - ECNext Ranbaxy, GlaxoSmithKline reach settlement - Jan 22, 2008 The terms of the settlement provide that Ranbaxy may distribute a generic version of Sumatriptan Succinate tablets in multiple strengths of 25 mg, ... Hindu … Treatment - Trexima(R) (sumatriptan succinate and naproxen sodium)... - Oct 16, 2005 GlaxoSmithKline (NYSE: GSK) and POZEN Inc. (NASDAQ: POZN), announced today that the New Drug Application (NDA) for Trexima(R) has been accepted for review ... Medical News Today - Medical News Today (press release) … Laboratories (MYL) Receives FDA Approval for Sumatriptan Succinate... - May 24, 2006 Sumatriptan Succinate Tablets are indicated for the acute treatment of migraine headaches. They are the generic version of GlaxoSmithKline's Imitrex® ... StreetInsider.com - StreetInsider.com (subscription) … Approval to Market Sumatriptan Succinate Tablets. - PR Newswire |... - Aug 2, 2005 Ranbaxy Receives Tentative Approval to Market Sumatriptan Succinate Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) ... - Mar 22, 2007 POZEN Inc. (NASDAQ: POZN), today announced the amended response to a previous FDA approvable letter for Trexima(TM) has been accepted for review by the US ... Genetic Engineering News - Genetic Engineering News (press release) … Tentative Approval of Sumatriptan Succinate Tablets. - M2 Presswire... - Nov 29, 2006 Teva Announces Tentative Approval of Sumatriptan Succinate Tablets. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Wockhardt gets approval for Sumatriptan Succinate injection - Aug 25, 2008 Wockhardt has received tentative approval from the US Food and Drug Administration (USFDA) to make and sell Sumatriptan Succinate injection, in the strength ... Myiris.com … Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) ... - Nov 1, 2007 CHAPEL HILL, NC -- POZEN Inc. (NASDAQ:POZN) announced today that its amended response to the FDA approvable letter for Trexima received on August 1, ... Free with registration - Business Wire - AccessMyLibrary.com … Occurred Earlier With Sumatriptan Succinate/Naproxen Sodium Combi - Sep 20, 2006 LONDON, UK -- September 20, 2006 -- For migraine sufferers, the rate at which their migraine medications are absorbed into the blood stream may make a ... DG News Ranbaxy, Glaxosmithkline reach settlement over Imitrex - Jan 21, 2008 The terms of the settlement provide that Ranbaxy may distribute a generic version of Sumatriptan Succinate tablets in multiple strengths of 25 mg, ... Free with registration - PTI - The Press Trust of India Ltd - AccessMyLibrary.com Ranbaxy Receives Tentative Approval to Market Sumatriptan Succinate … - Aug 2, 2005 Total annual market sales for Sumatriptan Succinate Tablets were $857 million ... Sumatriptan Succinate Tablets (Imitrex(R))* Tablets are indicated for the ... $4.95 - PR Newswire - ECNext … Single Tablet Containing Sumatriptan Succinate And Naproxen Sodium - Apr 10, 2006 ...(AAN) describe multiple benefits of a single tablet containing sumatriptan succinate and naproxen sodium for the acute treatment of migraine headaches. ... Medical News Today - Medical News Today (press release) … FDA Acceptance of its Sumatriptan Succinate Injection ANDA With … - Jan 10, 2005 Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand name Imitrex(R) and is used for the acute treatment of migraine attacks with ... $4.95 - PR Newswire - ECNext … for Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) for... - Aug 18, 2008 ...the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology (TM), and naproxen sodium, in a single tablet for ... businesswire.com … Tentative Approval for Sumatriptan Succinate Tablets. - PR... - May 24, 2006 Mylan Announces Tentative Approval for Sumatriptan Succinate Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … FDA Acceptance of its Sumatriptan Succinate Injection ANDA Wi - Jan 10, 2005 Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand name Imitrex(R) and is used for the ... Read all of this article with a FREE ... Pay-Per-View - PR Newswire - HighBeam Research Teva Announces Tentative Approval Of Sumatriptan Succinate Tablets - Dec 1, 2006 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for the Company's ... Medical News Today - Medical News Today (press release) Press Release: Par Pharmaceutical Begins Shipment of Sumatriptan … - Nov 6, 2008 Important information about sumatriptan succinate injectables. Sumatriptan Succinate Injection is indicated for 1) the acute treatment of migraine attacks ... Pay-Per-View - PR Newswire - HighBeam Research … Federal District Court Opinions - IN RE SUMATRIPTAN SUCCINATE … - Aug 9, 2005 IN RE SUMATRIPTAN SUCCINATE PATENT LITIGATION (JPML 2005) 381 F. Supp.2d 1378 IN RE SUMATRIPTAN SUCCINATE PATENT LITIGATION. Glaxo Group, Ltd. v. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw FDA Approves New Formulation of Imitrex (Sumatriptan Succinate) … - Feb 2, 2006 2006 -- The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex (sumatriptan succinate) Injection that allows a ... DG News Press Release: Ranbaxy Announces Settlement of Possible Imitrex(R) … - Jan 21, 2008 The annual market sales for Sumatriptan Succinate (Imitrex(R)) were USD 985 million (IMS-MAT: ... Sumatriptan Succinate Injection is not for use in the . ... Pay-Per-View - PR Newswire - HighBeam Research … for Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) for... - Aug 8, 2005 ...the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology (TM), and naproxen sodium, in a single tablet for ... $4.95 - Business Wire - ECNext … Drug Candidate For ImplaJect(R) Development, Sumatriptan Succinate - Mar 1, 2006 ...today announced the selection of Sumatriptan Succinate as its lead drug compound at the Needle-Free and Auto Injector Conference in London. ... Medical News Today - Medical News Today (press release) … Announce Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) … - Oct 11, 2005 Trexima is the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology(TM), and naproxen sodium, in a single tablet ... $4.95 - Business Wire - ECNext … Of Trexima(R) (sumatriptan Succinate/naproxen Sodium) Across M - Sep 25, 2006 New data examining more than 4200 migraine attacks in more than 1100 patients demonstrated that Trexima delivered consistent efficacy over multiple migraine ... Medical News Today - Medical News Today (press release) … Shows Imitrex(R) (Sumatriptan Succinate) Tablets Formulated With... - Jun 27, 2005 PHILADELPHIA, June 27 /PRNewswire/ -- New data show that Imitrex Tablets formulated with RT Technology disintegrated six times faster and were absorbed more ... RedOrbit FDA Approves New Formulation of Imitrex Sumatriptan Succinate … - Feb 7, 2006 The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex Injection that allows a convenient way for patients to take a ... DentalPlans.com Generic name: Sumatriptan succinate - Dec 1, 2005 Imitrex is prescribed for the treatment of a migraine attack with or without the presence of an aura (visual disturbances, usually sensations of halos or ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com References.(THE SELECTION AND USE OF ESSENTIAL MEDICINES) - Jan 1, 2007 Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. ... Free with registration - Technical Report Series - AccessMyLibrary.com Article: The Dominion Post, Morgantown, W.Va., Business Briefs... - May 26, 2006 Sumatriptan Succinate Tablets are indicated for the acute treatment of migraine ... Article: RANBAXY GETS USFDA APPROVAL FOR SUMATRIPTAN SUCCINATE ... ... Pay-Per-View - Dominion Post - HighBeam Research New and generic drug approvals: Sumatriptan Succinate Injection. - Oct 17, 2006 On 17 Oct 2006, the US Food and Drug Administration announced the tentative approval of ANDA 077332 for Sumatriptan Succinate Injection. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones Article: FDA tentative generics approvals--2006.(Special Report)(List)... - Feb 19, 2007 10/16/2006 500 mg/vial Industries Ltd. Sumatriptan succinate injection, ... Pliva Hrvatska D.O.O. 11/28/2006 20 ml vials Sumatriptan succinate tablets, ... Pay-Per-View - Chain Drug Review - HighBeam Research New and generic drug approvals: Sumatriptan Succinate Tablets. - Dec 5, 2006 On 5 Dec 2006, the US Food and Drug Administration announced the tentative approval of ANDA 076840 for Sumatriptan Succinate Tablets. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones Press Release: Trexima(TM) (Sumatriptan/Naproxen Sodium) Superior … - Apr 3, 2007 In addition ... the proposed brand name Trexima(TM) (sumatriptan succinate/naproxen sodium). Patient Satisfaction ... ... Pay-Per-View - PR Newswire - HighBeam Research Generic makers see opportunity in '08 expirations.(Generics) - Feb 11, 2008 The settlement will allow Ranbaxy to exclusively sell the generic form of the drug, sumatriptan succinate tablets, for 180 days beginning in December 2008. ... Free with registration - Drug Store News - AccessMyLibrary.com Spectrum announces initiation of Imitrex injection patent challenge. - Feb 1, 2005 Spectrum's Abbreviated New Application (ANDA) for sumatriptan succinate ... Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com NASCAR: JOE GIBBS RACING: JJYeley - Home Away from Home - Aug 2, 2006 18 Imitrex® (sumatriptan succinate) Chevrolet for Joe Gibbs Racing came to NASCAR by way of the Indianapolis-based United States Auto Club (USAC). ... noticias.info NASCAR: JOE GIBBS RACING: JGR Race Report - Indianapolis - Aug 6, 2006 18 Imitrex® (sumatriptan succinate) Chevrolet, finished a disappointing 34th after holding steady in either the 10th or 11th spot for much of the day. ... noticias.info INDIAN NEWSPAPER HIGHLIGHTS - FEB 1, 2008. - Feb 1, 2008 Aurobindo Pharma (BSE:524804) has received tentative approval from the US Food and Drug Administration to manufacture and market Sumatriptan Succinate ... Free with registration - AsiaPulse News - AccessMyLibrary.com FDA tentative generics approvals--2005.(Special Report)(Illustration) - Feb 27, 2006 4 Taro Pharmaceutical mg/5 ml Industries Ltd. Sumatriptan succinate tablets 100 Ranbaxy Laboratories Ltd. mg (base) Sumatriptan succinate tablets 25 mg ... Free with registration - Chain Drug Review - AccessMyLibrary.com Spectrum Pharmaceuticals Announces Initiation of Imitrex(R) Injection... - Feb 19, 2005 Spectrum's Abbreviated New Application (ANDA) for sumatriptan succinate ... Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand ... $4.95 - PR Newswire - ECNext Press Release: New Data Presented on Satisfaction, Productivity and … - Apr 5, 2006 ...(AAN) describe multiple benefits of a single tablet containing sumatriptan succinate and naproxen sodium for the acute treatment of migraine headaches. ... Pay-Per-View - PR Newswire - HighBeam Research FDA tentative generics approvals--2005.(Special Report)(Illustration)... - Feb 27, 2006 4 Taro Pharmaceutical mg/5 ml Industries Ltd. Sumatriptan succinate tablets 100 Ranbaxy Laboratories Ltd. mg (base) Sumatriptan succinate tablets 25 mg ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: New Data Show Peak Concentration of Sumatriptan … - Sep 20, 2006 Article: POZEN Announces Trexima(TM) (Sumatriptan Succinate and ... Business Wire; March 22, 2007 ; 700+ words ... ... treatment of migraine in adults. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Data Presented on Satisfaction, Productivity and … - Apr 6, 2006 Article: POZEN Announces Trexima(TM) (Sumatriptan Succinate and ... Business Wire; March 22, 2007 ; 700+ words ... ... formulated with RT Technology[TM], ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Pivotal Trial Data Demonstrated Superior Clinical ... - Apr 5, 2006 Article: POZEN Announces Trexima(TM) (Sumatriptan Succinate and ... Business Wire; March 22, 2007 ; 700+ words ... ... formulated with RT Technology[TM], ... Pay-Per-View - PR Newswire - HighBeam Research New Data Presented on Satisfaction, Productivity and Long-Term Safety... - Apr 5, 2006 ...(AAN) describe multiple benefits of a single tablet containing sumatriptan succinate and naproxen sodium for the acute treatment of migraine headaches. ... Free with registration - PR Newswire - AccessMyLibrary.com Spectrum Pharmaceuticals CEO Reviews Product Portfolio, Recent … - Jun 23, 2005 One of the pending ANDAs includes a Paragraph IV challenge for sumatriptan succinate injection, the generic from of GlaxoSmithKline's Imitrex(R) injection, ... $4.95 - PR Newswire - ECNext Sumatriptan–naproxen combination for acute migraine - Jun 12, 2007 To evaluate the efficacy and safety of a fixed-dose tablet containing sumatriptan succinate and naproxen sodium for the treatment of acute migraine. ... Nature.com Spectrum Pharmaceuticals Announces Filing of Its Ninth ANDA With the ... - Feb 24, 2005 Spectrum Pharmaceuticals currently has eight ANDAs that are pending at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate ... RedOrbit … Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Nap... - Sep 20, 2006 New Data Show Consistent Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Across Multiple Migraine Attacks. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Analysis Shows Patients Who Treat Their Migraine … - Sep 20, 2006 New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Have Higher Sustained Pain-Free ... Pay-Per-View - PR Newswire - HighBeam Research NASCAR: JOE GIBBS RACING: JJ Yeley - Hooray for Hollywood - Aug 29, 2006 18 Imitrex® (sumatriptan succinate) Chevrolet for Joe Gibbs Racing, is starring in the same type of role, except he's not in a movie. ... noticias.info Natco Pharma gets European approvals. - Feb 6, 2005 ...(CoS) from the European Pharmacopoeia for two of its active pharmaceutical ingredients - Ondansetron hydrochloride dihydrate and Sumatriptan succinate. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com NATCO receives CoS for APIs - Feb 10, 2005 ...of the European Pharmacopoeia for its active pharmaceutical ingredients (APIs)- Ondansetron Hydrochloride Dihydrate and Sumatriptan Succinate. ... expresspharmapulse.com Dr. Reddy's Announces Settlement of Imitrex Litigation with … - Nov 10, 2006 ...has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline's Imitrex tablets. ... ag-IP-news Agency טבע: ×?ישור FDA לייצור תרופה לטיפול בכ×?בי ר×?ש - Nov 29, 2006 ...×¢×? קבלתו, טבליות ×”-Sumatriptan Succinate של טבע יהיו הגירסה ×”×’× ×¨×™×ª לטבליות Imitrex של חברת GlaxoSmithKline. ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª Sun Pharma opts for out-of-court deals - Dec 11, 2007 In October last year, Dr Reddy's also had settled the long-pending patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, ... Business Standard Migraine; US FDA acceptance for review of ANDA for migraine headache ... - Feb 7, 2005 Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand name Imitrex and is used for the acute treatment of migraine attacks with or ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Dr Reddy's signs off a forgettable year - May 22, 2008 ...blockbuster anti-migrane drug, Imitrex, generically known as Sumatriptan Succinate which is worth around $1 billion in sales per year. ... सिफी - सिफी Migraine; US FDA acceptance for review of ANDA for migraine headache ... - Feb 13, 2005 Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand name Imitrex and is used for the acute treatment of migraine attacks with or ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Spectrum Pharmaceuticals, Inc. US FDA acceptance for review of ANDA … - Feb 9, 2005 Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand name Imitrex and is used for the acute treatment of migraine attacks with or ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Teva: GSK's latest headache - Nov 30, 2006 Teva's tentatively approved application for sumatriptan succinate includes tablets ... Sumatriptan succinate tablets represent a valuable addition to Teva's ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Press Release: Spectrum Pharmaceuticals Announces Initiation of... - Feb 19, 2005 Spectrum's Abbreviated New Application (ANDA) for sumatriptan succinate ... Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Spectrum Pharmaceuticals Announces Agreement With … - Nov 13, 2006 GlaxoSmithKline's Imitrex Injection (sumatriptan succinate injection) for the acute treatment of migraine attacks and the acute treatment of cluster ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Spectrum Pharmaceuticals Announces Filing of Its Ninth... - Feb 24, 2005 Spectrum Pharmaceuticals currently has eight ANDAs that are pending at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Spectrum Pharmaceuticals Announces Filing of Twelfth … - Aug 31, 2005 Spectrum Pharmaceuticals says that its Abbreviated New Drug Application for sumatriptan succinate injection 6mg/0.5mL, submitted last October, ... Pay-Per-View - PR Newswire - HighBeam Research Patents; Patent challenge of injection to treat migraine attacks in... - Mar 25, 2005 Spectrum's abbreviated new application (ANDA) for sumatriptan succinate ... Sumatriptan succinate injection is marketed by GlaxoSmithKline under the brand ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Press Release: Spectrum Pharmaceuticals Announces Filing of Its... - Feb 22, 2005 Spectrum Pharmaceuticals currently has seven ANDAs that are pending at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate ... Pay-Per-View - PR Newswire - HighBeam Research Community Bank declares regular, special dividend - May 25, 2006 Sumatriptan Succinate tablets, used for treatment of migraine headaches, are the generic version of GlaxoSmithKline's Imitrex tablets, which had annual US ... $2.95 - Observer-Reporter - NewsBank Press Release: Spectrum Pharmaceuticals Announces Filing of Its Tenth... - Apr 8, 2005 Spectrum Pharmaceuticals currently has nine ANDAs that are pending at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate ... Pay-Per-View - PR Newswire - HighBeam Research BRIEFING - ASIA HEALTH - AUG 4, 2005. - Aug 4, 2005 NEW DELHI - Ranbaxy Laboratories (BSE:600359) said it has received USFDA tentative approval for Sumatriptan Succinate Tablets. ... $4.95 - AsiaPulse News - ECNext Press Release: Cobalt Announces Settlement of Imitrex(R) Litigation... - Nov 15, 2006 The terms of the settlement, which remain subject to government review, provide that Cobalt may distribute a generic version of sumatriptan succinate ... Pay-Per-View - PR Newswire - HighBeam Research Cobalt Announces Settlement of Imitrex(R) Litigation With … - Nov 15, 2006 The terms of the settlement, which remain subject to government review, provide that Cobalt may distribute a generic version of sumatriptan succinate ... $4.95 - PR Newswire - ECNext Press Release: POZEN Inc. and GlaxoSmithKline Report Receipt of … - Jun 9, 2006 Article: POZEN Announces Trexima(TM) (Sumatriptan Succinate and ... Business Wire; March 22, 2007 ; 700+ words ... ... response to a previous FDA approvable ... Pay-Per-View - PR Newswire - HighBeam Research Meet Malav, the charismatic CEO of Ranbaxy - Jun 11, 2008 ...with Astellas/Boehringer Ingelheim to dismiss their US court case over Flomax (Tamsulosin capsules) and settled with GSK over Sumatriptan Succinate, ... Rediff Is Your Headache a Migraine? - Oct 29, 2007 ..."Because I talked to my doctor," Aikman said, "he was able to diagnose me with migraines and prescribe Imitrex(R) (sumatriptan succinate) Tablets. ... Free with registration - PR Newswire - AccessMyLibrary.com Ranbaxy settles with GlaxoSmithKline on Imitrex - Jan 21, 2008 Under the terms of the settlement, Ranbaxy may sell a generic version, sumatriptan succinate tablets, in multiple strengths in the United States from ... Livemint Trade Alert for Pozen, Inc. - Mar 23, 2007 Trexima is a proprietary single tablet containing sumatriptan succinate and naproxen sodium. The company entered into a collaboration agreement with ... Free with registration - M2 Presswire - AccessMyLibrary.com Mylan仿制è?¯ç‰©èŽ·FDA临时许å?¯ - May 25, 2006 ...sumatriptan succinateè?¯ç‰©å?¯ç”¨æ–¼æ²»ç–—å??头痛，这ç§?è?¯ç‰©æ˜¯è‘›å…°ç´ (GlaxoSmithKline) (GSK) å…¬å?¸Imitrexè?¯ç‰©çš„仿制è?¯ç‰©ã€‚截æ¢2006å¹´3月31日，Imitrexè?¯ç‰©åœ¨ç¾Žå›½çš„年度销 ... 新浪网 LSD cured my headaches - Oct 7, 2008 Besides, according to IMS Health data, annual sales of sumatriptan succinate tablets in the US over 2006/07 were $950m. Why spend millions developing a ... Belfast Telegraph Article: THISWEEK; [visit www.washingtonpost.com] - The Washington … - Jun 20, 2005 GlaxoSmithKline, the maker of Imitrex(R) (sumatriptan succinate) tablets, announced today a pledge to donate five dollars to the American Council of ... Pay-Per-View - Washington Post - HighBeam Research Sensex ends flat after breaching 7,800 mark. - Aug 4, 2005 ...that it has received a tentative approval from the US Food and Drug Administration (FDA) to manufacture and market Sumatriptan Succinate tablets. ... Free with registration - Economic Times - AccessMyLibrary.com Breather for local pharma majors in sight - Mar 16, 2007 Reddy's, which settled a spat with GlaxoSmithKline over migraine drug Imitrex (sumatriptan succinate), will exclusively distribute an authorised generic ... Daily News & Analysis Dr Reddy's Q2 net trebles on record sales - Oct 28, 2006 Responding to a query on the patent litigation settlement entered into with GlaxoSmithKline recently relating to sumatriptan succinate tablets, ... Hindu Business Line Pozen migraine treatment wins European patent - Jan 25, 2005 ...won patent protection in the United States and Australia for the single tablet migraine treatment containing sumatriptan succinate and naproxen sodium. ... Bizjournals.com Ranbaxy gets FDA nod for migrane drug - Aug 8, 2005 ...and Drug Administration (US FDA) to manufacture and market sumatriptan succinate tablets, for the treatment of acute migraine attacks in adults, in US. ... Business Standard SMS Pharma fixes IPO price band at Rs 360-380 - Jan 29, 2007 It is mainly engaged in manufacturing bulk drugs like Ranitidine HCl, Sumatriptan Succinate, Sildenafil Citrate, Omeprazole pellets, Ramipril, ... Moneycontrol.com Infosys to set up software unit in Shanghai - Aug 3, 2005 The company said Sumatriptan Succinate tablets has total annual market sales of $857 million at the end of March 2005, said a statement from Ranbaxy ... Pay-Per-View - Hindustan Times - Factiva, from Dow Jones The Record (Bergen County, NJ) - May 8, 2008 Imitrex Injection (sumatriptan succinate injection) is used for the acute treatment of migraine attacks with or without aura, and the acute treatment of ... Pay-Per-View - The Record - HighBeam Research Press Release: FDA Issues Second Approvable Letter for Trexima(TM). -... - Aug 2, 2007 About Imitrex(R) (sumatriptan succinate) Tablets. Read all of this article with a FREE trial. COPYRIGHT 2007 PR Newswire Association LLC. ... Pay-Per-View - PR Newswire - HighBeam Research New Data Demonstrate Sustained Efficacy of Single Tablet Combination ... - Jun 26, 2006 ...under review by the United States Food and Drug Administration (FDA) under the proposed trade name Trexima(TM) (sumatriptan succinate/naproxen sodium). ... Free with registration - PR Newswire - AccessMyLibrary.com Spectrum Pharmaceuticals, Inc. Announces Financial Update and … - Mar 14, 2007 ...and Generics - ANDA for sumatriptan succinate injection approved tentatively by FDA - Received $5 million payment from Par Pharmaceutical Companies, ... Free with registration - PR Newswire - AccessMyLibrary.com Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline … - Nov 13, 2006 GlaxoSmithKline's Imitrex Injection (sumatriptan succinate injection) for the acute treatment of migraine attacks and the acute treatment of cluster ... Free with registration - PR Newswire - AccessMyLibrary.com FDA Requests More Information on Pozen and GSK's Migraine Drug - Jun 12, 2006 Sumatriptan succinate is the active ingredient in GSK's already marketed migraine treatment Imitrex. Naproxen sodium is a non-steroidal anti-inflammatory ... RedOrbit Brand Names/Synonyms: sumatriptan succinate is also known by the following brand names and/or synonymsCHEMBANK1724; Imigran; Imitrex; Sumatran; Sumatriptan; Sumatriptan Succinate; Sumatriptanum [Inn-Latin]; Sumax Drug Category: sumatriptan succinate is categorized under the following by the FDA: Vasoconstrictor Agents; Selective Serotonin Agonists; ATC:N02CC01 Dosage Forms: Tablets; Injection; Nasal spray Absorption: ~15% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
